share_log

丽珠医药(01513.HK):注射用醋酸西曲瑞克获得美国FDA批准

Livzon Pharmaceuticals (01513.HK): Cetrorelix acetate for injection was approved by the US FDA

Gelonghui Finance ·  Apr 26 05:59

On April 26, GLONGHUI Pharmaceutical (01513.HK) issued an announcement. Recently, Lizhu Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received an ANDA approval notice (ANDA number: 214540) issued by the US Food and Drug Administration (hereinafter referred to as the “US FDA”) to approve the marketing and sale of injectable cetrorelix acetate developed by the company in the US.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment